<DOC>
	<DOCNO>NCT01076140</DOCNO>
	<brief_summary>The purpose study directly compare blood pressure ( hypertension ) reduction effect lisinopril nebivolol patient develop new onset worsen hypertension treat bevacizumab .</brief_summary>
	<brief_title>Blood Pressure Effects Nebivolol Versus Lisinopril New Onset Worsening Hypertension Induced Bevacizumab</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Nebivolol</mesh_term>
	<mesh_term>Lisinopril</mesh_term>
	<criteria>Patients currently treat University Mississippi Medical Center Oncology Clinic Patient treat bevacizumab either alone combination agent cancer Patient blood pressure &gt; 140 mmHg ( systolic ) &gt; 90 mmHg ( diastolic ) , either treat untreated medication hypertension Patients may currently medications hypertension ( Beta blocker , ACEI , ARB ) ; continue dose throughout study Patients &gt; 18 year age Patients receive bevacizumab therapy approximately every 2 week History ACEI ARB induce angioedema idiopathic/hereditary angioedema Patient currently treat Beta blocker , ACEI , ARB history intolerance medication class Hyperkalemia , define potassium value &gt; 5 mEq/L Pregnancy breastfeed Severe renal impairment ( eGFR &lt; 30 mL/min ) Moderate hepatic impairment identify physician Currently take CYP2D6 inducer ( rifampin , carbamazepine dexamethasone ) inhibitor ( bupropion , fluoxetine , paroxetine , duloxetine , etc . ) History clinically significant EKG abnormality would contraindicate beta blocker use Recent stroke ( &lt; 6 month ) Recent myocardial infarction ( &lt; 6 month ) Congestive heart failure Severe asthma COPD Diagnosed obstructive sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>Hypertension result bevacizumab therapy</keyword>
</DOC>